Demographic Variation Assessment

Demographic variation assessment characterises pharmacokinetic differences across age, gender, and ethnic groups. Paediatric populations exhibit different pharmacokinetics reflecting developmental physiology. Elderly patients show altered metabolism and elimination. Female-male differences reflect hormone and body composition variations. Ethnic polymorphisms explain population-specific pharmacokinetics.

Population pharmacokinetics quantitate demographic effects. Regulatory submissions address demographic stratification. Clinical trials enrolling diverse populations establish broad efficacy-safety profiles. Post-approval monitoring detects unrecognised demographic variations. Personalised medicine tailors treatment to individual characteristics.